Literature DB >> 33451318

Correction to: Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline.

Julia Stockmann1,2, Inge M W Verberk3,4, Nina Timmesfeld5, Robin Denz5, Brian Budde1,2, Julia Lange-Leifhelm1,2, Philip Scheltens4, Wiesje M van der Flier4, Andreas Nabers1,2, Charlotte E Teunissen3, Klaus Gerwert6,7.   

Abstract

Entities:  

Year:  2021        PMID： 33451318      PMCID： PMC7809829          DOI： 10.1186/s13195-021-00770-2

Source DB:  PubMed          Journal:  Alzheimers Res Ther            Impact factor:   6.982


× No keyword cloud information.
  1 in total

1.  Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline.

Authors:  Julia Stockmann; Inge M W Verberk; Charlotte E Teunissen; Klaus Gerwert; Nina Timmesfeld; Robin Denz; Brian Budde; Julia Lange-Leifhelm; Philip Scheltens; Wiesje M van der Flier; Andreas Nabers
Journal:  Alzheimers Res Ther       Date:  2020-12-24       Impact factor: 6.982
  1 in total
  1 in total

1.  Chemical-Driven Outflow of Dissociated Amyloid Burden from Brain to Blood.

Authors:  Donghee Lee; Hyunjin Vincent Kim; Hye Yun Kim; YoungSoo Kim
Journal:  Adv Sci (Weinh)       Date:  2022-02-02       Impact factor: 17.521
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.